Granite Group Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,138
Closed -$476K 98
2024
Q1
$476K Hold
1,138
0.32% 52
2023
Q4
$472K Buy
+1,138
New +$472K 0.33% 48